Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

Recent epidemiological studies show a strong reduction in the incidence of Alzheimer's disease in patients treated with cholesterol-lowering statins. Moreover, elevated Aβ42 levels and the ɛ4 allele of the lipid-carrier apolipoprotein E are regarded as risk factors for sporadic and familial Alzheimer's disease. Here we demonstrate that the widely used cholesterol-lowering drugs simvastatin and lovastatin reduce intracellular and extracellular levels of Aβ42 and Aβ40 peptides in primary cultures of hippocampal neurons and mixed cortical neurons. Likewise, guinea pigs treated with high doses of simvastatin showed a strong and reversible reduction of cerebral Aβ42 and Aβ40 levels in the cerebrospinal fluid and brain homogenate. These results suggest that lipids are playing an important role in the development of Alzheimer's disease. Lowered levels of Aβ42 may provide the mechanism for the observed reduced incidence of dementia in statin-treated patients and may open up avenues for therapeutic interventions.

[1]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[2]  G. Celesia,et al.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.

[3]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[4]  Min Xu,et al.  Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  L. Lannfelt,et al.  Quantification of Alzheimer Amyloid β Peptides Ending at Residues 40 and 42 by Novel ELISA Systems , 2000, Molecular medicine.

[6]  P. George-Hyslop.  Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.

[7]  Guorong Xu,et al.  Comparative regulation of hepatic sterol 27-hydroxylase and cholesterol 7alpha-hydroxylase activities in the rat, guinea pig, and rabbit: effects of cholesterol and bile acids. , 1999, Metabolism: clinical and experimental.

[8]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Keyomarsi,et al.  Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D J Stephens,et al.  The role of cholesterol in the biosynthesis of beta-amyloid. , 1999, Neuroreport.

[11]  T. Hartmann,et al.  Intracellular biology of Alzheimer’s disease amyloid beta peptide , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[12]  T. Mizuno,et al.  Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells. , 1998, Biochimica et biophysica acta.

[13]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Kodama,et al.  βAPP γ‐secretase and SREBP site 2 protease are two different enzymes , 1998 .

[15]  J. Laguna,et al.  Influence of lipid profile and fatty acid composition on the oxidation behavior of rat and guinea pig low density lipoprotein. , 1998, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[16]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[17]  S. Paul,et al.  Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.

[18]  L. Schad,et al.  Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging , 1997, Molecular Psychiatry.

[19]  R. Doms,et al.  Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.

[20]  C. Masters,et al.  Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.

[21]  Y. Ihara,et al.  Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42* , 1997, The Journal of Biological Chemistry.

[22]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[23]  C. Masters,et al.  Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[25]  G. Thorgeirsson,et al.  Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. , 1996, Archives of internal medicine.

[26]  C. Masters,et al.  The beta‐amyloid domain is essential for axonal sorting of amyloid precursor protein. , 1996, The EMBO journal.

[27]  Hans Förstl,et al.  Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.

[28]  J. Pitha,et al.  Intracellular Trafficking of Cholesterol Monitored with a Cyclodextrin* , 1996, The Journal of Biological Chemistry.

[29]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[30]  C. Masters,et al.  Alzheimer's Disease βA4 Protein Release and Amyloid Precursor Protein Sorting Are Regulated by Alternative Splicing* , 1996, The Journal of Biological Chemistry.

[31]  Nobuhiro Suzuki,et al.  Amyloids and Are Generated Intracellularly in Cultured Human Neurons and Their Secretion Increases with Maturation (*) , 1996, The Journal of Biological Chemistry.

[32]  B. de Strooper,et al.  Production of intracellular amyloid‐containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. , 1995, The EMBO journal.

[33]  S. Younkin.  Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .

[34]  J. Slattery,et al.  Scandinavian simvastatin study (4S) , 1994, The Lancet.

[35]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[36]  Stephen W. Scheff,et al.  Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.

[37]  J. Trojanowski,et al.  Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[39]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[40]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[41]  F. Czubayko,et al.  A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. , 1991, Journal of lipid research.

[42]  Y. Horsmans,et al.  Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor). , 1990, Pharmacology & toxicology.

[43]  R. Tilvis,et al.  Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. , 1990, American journal of epidemiology.

[44]  J. Volpe,et al.  Cell Cycle‐Specific Requirement for Mevalonate, but Not for Cholesterol, for DNA Synthesis in Glial Primary Cultures , 1987, Journal of neurochemistry.

[45]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[46]  J. L. Robinson,et al.  Hypocholesteremia induced by orotic acid: dietary effects and species specificity. , 1984, The Journal of nutrition.

[47]  C. West,et al.  The density profile and cholesterol concentration of serum lipoproteins in domestic and laboratory animals. , 1982, Comparative biochemistry and physiology. B, Comparative biochemistry.

[48]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.